Report #2825151

Received Feb 7, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

A half of the adult dosage of Hepatitis A was administered to 16 year old; This non-serious case was reported by a consumer via patient support programs and described the occurrence of adult product administered to child in a 16-year-old female patient who received HAV (Havrix adult) for prophylaxis. On an unknown date, the patient received Havrix adult .5 ml. On an unknown date, an unknown time after receiving Havrix adult, the patient experienced adult product administered to child (Verbatim: A half of the adult dosage of Hepatitis A was administered to 16 year old). The outcome of the adult product administered to child was unknown. Additional Information: GSK Receipt Date: 08-JAN-2025 A half of the adult dosage of Hepatitis A was administered to 16 year old, which led to adult product administered to child.